Clinical Trial Update: Efficacy and Safety of Sublingual Immunotherapy (SLIT) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of sublingual immunotherapy (SLIT) for allergic rhinitis. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Sublingual immunotherapy (SLIT) (Sublingual immunotherapy)

Snippet

Sponsor: Roxall Medizin | Conditions: Allergic Rhinitis | Phase 3 | Status: UNKNOWN